Phase III Clinical Trials of Cuba’s Soberana 02 Vaccine Begin
Phase III clinical trials of Cuba’s Soberana 02 vaccine for COVID-19 from the Finlay Vaccine Institute will begin after receiving approval from Cuba’s regulatory authority, the Center for State Control of Medicines, Equipment and Medical Devices (CECMED). Sobe... More »